Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study
Authors
José Castillo‐Mancilla (ORCID: https://orcid.org/0000-0003-1242-1745)
Marcia Wang
Shiven Chabria
Fangfang Du
Andrew Clark (ORCID: https://orcid.org/0000-0002-0272-4788)
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study
José Castillo‐Mancilla, Marcia Wang, Shiven Chabria, Fangfang Du et al.
Citations
4 citations
Journal
Open Forum Infectious Diseases
Topics
HIV-related health complications and treatments
Field-Weighted Citation Impact (FWCI)
2.76
article
Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study
José Castillo‐Mancilla, Marcia Wang, Shiven Chabria, Fangfang Du, Andrew Clark, Manyu Prakash, Amy Pierce, Allan R. Tenorio